Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin

Hirofumi Yasui1 Takayuki Yoshino2 Narikazu Boku1 Yusuke Onozawa1 Shuichi Hironaka1 Akira Fukutomi1 Kentaro Yamazaki1 Keisei Taku1 Takashi Kojima1 and Nozomu Machida1

首页> 外文期刊>Japanese Journal of Clinical Oncology >Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin

【24h】

Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin

机译：氟嘧啶和伊立替康或氟嘧啶，伊立替康和奥沙利铂治疗失败后转移性结直肠癌患者S-1单一疗法的回顾性分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Japanese Journal of Clinical Oncology》 |2009年第5期|p.315-320|共6页
作者
Hirofumi Yasui1 Takayuki Yoshino2 Narikazu Boku1 Yusuke Onozawa1 Shuichi Hironaka1 Akira Fukutomi1 Kentaro Yamazaki1 Keisei Taku1 Takashi Kojima1 and Nozomu Machida1;
展开▼
作者单位

1Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka 2Division of Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin. [J] . Yasui H, Yoshino T, Boku N, Japanese journal of clinical oncology. . 2009,第5期

机译：氟嘧啶和伊立替康或氟嘧啶，伊立替康和奥沙利铂治疗失败后转移性结直肠癌患者S-1单一疗法的回顾性分析。
2. CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial [J] . Yuankai Shi, Jin Li, Jianming Xu, Cancer Communications . 2019,第1期

机译：CMAB009加上Irinotecan与Irinotecan-ock氟嘧啶和Oxaliplatin失败后的二线治疗，在KRAS野生型转移性结肠直肠癌患者中：有前景，开放标签，随机，第三阶段试验的有前景的发现
3. Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G) [J] . Sakai Daisuke, Taniguchi Hiroya, Sugimoto Naotoshi, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第1期

机译：Panitumumab Plus in Irinotecan与氟丙二屈氏蛋白酶酸难以氟嘧啶，Irinotecan和Oxaliplatin（Wjog 6510g）患者的随机素in inerucotecan对伊喹仑（Cetuximab）对氨基替康酸的氨管
4. Adequate Selection of Fluoropyrimidines for Colorectal Cancer [C] . H. Usuki, S. Akamoto, T. Sugiyama, Asian Federation of Coloproctology . 2005

机译：Adequate Selection of Fluoropyrimidines for Colorectal Cancer
5. Use and outcomes of newer chemotherapeutic agents in colorectal cancer patients using Irinotecan as a case study. [D] . Obeidat, Nour A. 2008

机译：以伊立替康为例的结直肠癌患者中新型化疗药物的使用和结果。
6. CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective open-label randomized phase III trial [O] . Yuankai Shi, Jin Li, Jianming Xu, 2019

机译：CMAB009加伊立替康与仅依立替康作为氟嘧啶和奥沙利铂治疗KRAS野生型转移性结直肠癌患者的二线治疗：前瞻性开放标签随机III期试验的有希望的发现
7. Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer : NORDIC 9 [O] . Winther, Stine Braendegaard, Österlund, Pia, Berglund, Åke, 2017

机译：随机研究比较了全剂量单药治疗（S-1，然后伊立替康）和减剂量联合治疗（S-1 /奥沙利铂，然后S-1 /伊立替康）作为老年转移性大肠癌患者的初始治疗的方法：NORDIC 9

Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin

著录项

相似文献

相关主题

期刊订阅